Healthcare / Biotechnology & Medical ResearchUpdated 2026-05-10 22:07 UTC

WSE/RDG stock hub

WSE/RDG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

WSE/RDGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

61.1M

Warsaw Stock Exchange

Market data

Price

Recent price action with selectable time range.

WSE/RDGWSE/RDG

—

Loading chart…

In the news

Latest news · WSE/RDG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E75.6

P25 n/aP50 n/aP75 n/a

ROE23.6

P25 n/aP50 n/aP75 n/a

ROIC17

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All WSE/RDG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

PLN

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Poland
Country code	PL
Employees	19.93
Employees Change	-10.07%
Employees Change Percent	-33.57
Enterprise value	PLN 64.2M
Exchange	Warsaw Stock Exchange
Financial currency	PLN
First seen	2026-05-10
Industry	Biotechnology & Medical Research
Isin	PLRADGN00014
Last refreshed	2026-05-10
Market cap	PLN 61.1M
Price	PLN 5.18
Price currency	PLN
Rev Per Employee	778,431.45x
Sector	Healthcare
Sic	2836
Symbol	wse/RDG
Website	https://www.read-gene.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.32%
EV Earnings	79.43x
EV/EBIT	61.59x
EV/EBITDA	42.99x
EV/FCF	-503.36x
EV/Sales	4.12x
FCF yield	-0.21%
P/B ratio	15.97x
P/E ratio	75.55x
P/S ratio	3.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.7%
EBITDA Margin	9.59%
Gross margin	93.56%
Gross Profit	PLN 14.6M
Gross Profit Growth	18.03%
Gross Profit Growth Q	10.78%
Gross Profit Growth3 Y	33.05%
Gross Profit Growth5 Y	21.42%
Net Income	PLN 808,327
Net Income Growth3 Y	55.92%
Net Income Growth5 Y	18.28%
Pretax Margin	5.19%
Profit Margin	5.19%
Profit Per Employee	PLN 40,416
ROA	4.34
Roa5y	-0.17
ROCE	7.4
ROE	23.64
Roe5y	-6.09
ROIC	17.02
Roic5y	-0.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16.45%
Cagr15y	1.74%
Cagr1y	12.13%
Cagr3y	17.41%
Cagr5y	9.98%
EPS Growth3 Y	55.93
EPS Growth5 Y	18.28
FCF Growth Q	-90%
OCF Growth	-90.36%
OCF Growth Q	-81.74%
OCF Growth3 Y	-16.62%
OCF Growth5 Y	-28.17%
Revenue Growth	17.67x
Revenue Growth Q	7.79x
Revenue Growth3 Y	29.07x
Revenue Growth5 Y	20.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	PLN 1.04
Assets	PLN 15.4M
Cash	PLN 5.2M
Current Assets	PLN 9.6M
Current Liabilities	PLN 1.3M
Debt	PLN 8.3M
Debt EBITDA	PLN 5.56
Debt Equity	PLN 2.17
Debt FCF	PLN -65.04
Equity	PLN 3.8M
Interest Coverage	3.15
Liabilities	PLN 11.5M
Long Term Assets	PLN 5.8M
Long Term Liabilities	PLN 10.3M
Net Cash	PLN -3.1M
Net Cash By Market Cap	PLN -5.13
Net Debt EBITDA	PLN 2.1
Net Debt Equity	PLN 0.82
Tangible Book Value	PLN 3.8M
Tangible Book Value Per Share	PLN 0.32
WACC	5.55

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	7.58
Inventory Turnover	10.34
Net Working Capital	PLN 3.2M
Quick ratio	7.52
Working Capital	PLN 8.3M
Working Capital Turnover	PLN 2.04

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	358.41%
1Y total return	12.12%
200-day SMA	5.65
3Y total return	61.88%
50-day SMA	5.34
50-day SMA vs 200-day SMA	50under200
5Y total return	60.87%
All Time High	10.98
All Time High Change	-52.82%
All Time High Date	2010-05-26
All Time Low	0.38
All Time Low Change	1,263.16%
All Time Low Date	2018-12-21
ATR	0.1
Beta	0.3
Beta1y	0.26
Beta2y	0.16
Ch YTD	-5.13
High	5.18
High52	6.9
High52 Date	2025-09-24
High52ch	-24.93%
Low	5.18
Low52	3.92
Low52 Date	2025-05-26
Low52ch	32.14%
Ma50ch	-2.96%
Price vs 200-day SMA	-8.37%
RSI	43.85
RSI Monthly	51.12
RSI Weekly	45.45
Sharpe ratio	0.5x
Sortino ratio	0.89
Tr YTD	-5.13
Tr15y	29.5%
Tr1m	-4.43%
Tr3m	-0.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	PLN 1M
Operating Income Growth Q	681.5
Operating Income Growth3 Y	53.85
Operating Income Growth5 Y	15.68
Operating margin	6.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,272,079%
Shares Insiders	7.16%
Shares Out	11,790,010
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	PLN -127,555
Average Volume	326.55x
Bv Per Share	0.32
CAPEX	PLN -329,205
Ch10y	358.4
Ch15y	29.5
Ch1m	-4.43
Ch1y	12.12
Ch3m	-0.38
Ch3y	61.88
Ch5y	60.87
Ch6m	-14.52
Change	0%
Change From Open	0
Close	5.18
Days Gap	0
Depreciation Amortization	451,077
Dollar Volume	108.8
Earnings Date	2026-05-13
EBIT	PLN 1M
EBITDA	PLN 1.5M
EPS	PLN 0.07
F Score	6
FCF	PLN -127,555
FCF EV Yield	-0.2x
FCF Per Share	PLN -0.01
Financing CF	-331,022
Fiscal Year End	December
Founded	2,005
Graham Number	0.70731
Graham Upside	-86.35
Investing CF	-41,744
Is Primary Listing	1
Last Earnings Date	2026-02-10
Last Report Date	2025-12-31
Lynch Fair Value	PLN 1.25
Lynch Upside	-75.81
Ma150	5.65
Ma150ch	-8.25%
Ma20	5.2
Ma20ch	-0.33%
Net CF	-171,115
Next Earnings Date	2026-05-13
Open	5.18
P OCF Ratio	302.9
Ppne	5,758,803
Price Date	2026-05-08
Price EBITDA	PLN 40.89
Ptbv Ratio	15.97
Relative Volume	0.06x
Revenue	15,568,629x
Tr6m	-14.52%
Volume	21
Z Score	4.83

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does WSE/RDG pay a dividend?

Capital-return profile for this ticker.

Performance

WSE/RDG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns WSE/RDG?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+7.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

WSE/RDG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.9

Neutral momentum band

Price vs 200-day MA

-8.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About WSE/RDG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current wse/RDG stock rating?

wse/RDG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full wse/RDG analysis?

The full report lives at /stocks/wse/RDG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for wse/RDG?

The latest report frames wse/RDG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the wse/RDG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.